Qiantang Longyue (杭州钱塘隆越生物科技) is a Hangzhou-based biotech founded in 2021 that develops innovative pharmaceutical packaging and drug-delivery systems, including COP prefillable syringes, ophthalmic and vaccine delivery devices, medical-aesthetics injection systems, nebulization devices and smart electronic injector pens. It operates an 8,000 m2 GMP-compliant Class C cleanroom with quality and R&D systems aligned with FDA, EU and NMPA requirements, offering drug companies one-stop custom solutions from design and validation through registration and commercial-scale manufacturing.
1
Round
1
Industry
4
Tags
Sep 17, 2026
Latest raise
Funding activity · 1 round
Sep 17, 2026
CNY 100M
Series B
Led by 惠每资本 (Himca Capital)
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
